Register Today!

July 31, 2025
Live Stream Conference - Virtual
Course# MEP26001 - Department: Epidemiology and Biostatistics

Overview

Now in its 22nd year, and presented by the Department of Epidemiology and Biostatistics of the University of California, San Francisco School of Medicine, this 1-day virtual course features an expert faculty that will discuss the epidemiology, pathophysiology, diagnosis, and treatment of osteoporosis. The course will critically review current treatment options. There will be an emphasis on recent developments and current controversies in the etiology, diagnosis, and management of osteoporosis. Additional special topics this year include exercise for fall and fracture prevention, nutrition and skeletal health, and the approach to the premenopausal woman with low bone mass or skeletal fragility.

TARGET AUDIENCE
The course will provide an update on current recommendations about screening and treatment of osteoporosis for health care providers working with osteoporosis patients. It will also benefit researchers, technologists, and pharmaceutical or device company professionals who would find additional scientific background in the disease helpful. No prior clinical or scientific training in osteoporosis is required.

Live Stream Meeting
This course will be offered as a virtual conference. Login instructions along with the digital syllabus will be shared with the attendees a week before the meeting. Included in your registration fee is access to the course recordings on demand after the conference and for 30 days after the course. You must tune in to the live conference (in person or remotely) to claim CME.

Objectives

• Screen for and diagnose osteoporosis according to the latest evidence-based standards of care;
• Interpret dual-energy X-ray absorptiometry (DXA) bone density scans and avoid common DXA pitfalls;
• Provide appropriate pharmacological treatment for osteoporosis, including antiresorptive and anabolic therapies;
• Assess the benefits and risks of continuing long-term antiresorptive osteoporosis therapy and determine optimal treatment duration;
• Recommend physical activity to optimize bone health and to help patients with skeletal fragility move safely;
• Provide evidence-based nutritional guidance for healthy bones;
• Evaluate and treat, when appropriate, the premenopausal woman with low bone mass or skeletal fragility

Dennis M. Black, PhD
Professor of Epidemiology and Biostatistics

Anne L. Schafer, MD
Professor of Medicine and of Epidemiology & Biostatistics, UCSF;
Endocrine Research Unit, San Francisco VA Medical Center